Skip to content

A Novel Bronchial Blocker Placement Technique for Thoracoscopic Surgery: A Randomized Controlled Trial

A Novel Bronchial Blocker Placement Technique for Thoracoscopic Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102970
Enrollment
Unknown
Registered
2025-05-22
Start date
2025-05-22
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary mass

Interventions

LBBP group :The Liu's method for bronchial blocker localization is adopted.
FOB group:Utilized by fiberoptic bronchoscopy

Sponsors

Weifang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Scheduled for thoracoscopic lung tumor resection; 2.No significant abnormalities were found in liver and kidney function. 3.American Society of Anesthesiologists (ASA) physical status classification I-II; 4.Body Mass Index (BMI) less than 35 kg/m^2;

Exclusion criteria

Exclusion criteria: 1.Patients with severe cardiovascular diseases; 2.Conditions leading to central nervous system disorders; 3.Severe pulmonary diseases, such as chronic obstructive pulmonary disease (COPD) or pulmonary atelectasis; 4.Emergency surgery cases;

Design outcomes

Secondary

MeasureTime frame
Airway pressure;Intubation time;Airway pressure;

Primary

MeasureTime frame
Rates of BB displacement;Single-attempt intubation success of BB;BB placement times;

Countries

China

Contacts

Public ContactZhenhai Liu

Weifang People's Hospital

wfsi2004@163.com+86 536 819 2179

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026